Medicus Pharma Ltd (NASDAQ:MDCX) is one of the Canadian penny stocks to buy right now. On November 18, Maxim Group analyst ...
TipRanks on MSN
Medicus Pharma Expands Phase 2 BCC Clinical Study to the UK
Medicus Pharma Ltd ( ($MDCX) ) just unveiled an announcement. Medicus Pharma Ltd. has received full regulatory and ethical approvals in the United ...
(RTTNews) - Medicus Pharma Ltd (MDCX) announced that it has submitted a Phase 2 clinical trial design or SKNJCT-004 to the UAE Department of Health or DOH for its non-invasive treatment for Basal Cell ...
THE SKNJCT-003 CLINICAL STUDY EXPANSION INTO THE UNITED KINGDOM TO FURTHER ENABLE GLOBAL PATIENT RECRUITMENT AND CLINICAL DATASET TOWARD A PIVOTAL STUDY PROGRAM PHILADELPHIA, PA / ACCESS Newswire / ...
"Innovative Technologies and Trends in AI, 3D Imaging, and Minimally Invasive Diagnostics Drive Growth in the Medical Imaging Market" BOSTON, May 6, 2025 /PRNewswire/ -- According to the latest study ...
SINGAPORE – Researchers from the Agency for Science, Technology and Research (A*STAR) and the National Healthcare Group (NHG) have jointly pioneered an innovative imaging technique combining ...
To form a cancer, cells need to accumulate oncogenic mutations that confer tumor-initiating properties. However, recent evidence has shown that oncogenic mutations occur at a surprisingly high ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback